aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Japan, Taiho Pharmaceutical Co., Ltd. specializes in pharmaceutical research with a core mission to improve global health through innovative treatments. The company's vision is to be a leader in oncology, allergy, and immunology therapies. Taiho offers a range of products, including prescription medications and over-the-counter drugs, focusing primarily on cancer treatment and supportive care. Their market focus spans both domestic and international territories, aiming to address unmet medical needs worldwide.
Notable affiliated people include key researchers and executives who have driven the company's innovative strides in oncology. Taiho has garnered significant investments from strategic partners within the pharmaceutical industry. Key achievements include the development of pioneering cancer treatments that have received regulatory approval in multiple countries. The company's impact is marked by its contributions to advancing cancer therapy, improving patient outcomes, and setting new standards in pharmaceutical care.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Pharmaceuticals
Technology
Biotech
Tags
Pharmaceuticals
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Taiho Pharmaceutical Co. founded?
Taiho Pharmaceutical Co. was founded in 1963.
Where is Taiho Pharmaceutical Co.’s headquarters located?
Taiho Pharmaceutical Co.’s headquarters is located in Tokyo, JP.
How many employees does Taiho Pharmaceutical Co. have?
Taiho Pharmaceutical Co. has 2500 employees as of Feb 4, 2024.
Add Comparison
Total Employees Over Time
2500
As of Feb 2024
Taiho Pharmaceutical Co. Address
Tokyo,
100-8210
Japan
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts